Annual CFF
$38.15 M
+$37.84 M+12167.20%
31 December 2023
Summary:
Cara Therapeutics annual cash flow from financing activities is currently $38.15 million, with the most recent change of +$37.84 million (+12167.20%) on 31 December 2023. During the last 3 years, it has fallen by -$989.00 thousand (-2.53%). CARA annual CFF is now -73.25% below its all-time high of $142.60 million, reached on 31 December 2019.CARA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$694.00 K
-$84.00 K-13.77%
30 September 2024
Summary:
Cara Therapeutics quarterly cash flow from financing activities is currently -$694.00 thousand, with the most recent change of -$84.00 thousand (-13.77%) on 30 September 2024. Over the past year, it has dropped by -$1.81 million (-162.19%). CARA quarterly CFF is now -100.50% below its all-time high of $138.37 million, reached on 30 September 2019.CARA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$34.49 M
-$1.81 M-4.99%
30 September 2024
Summary:
Cara Therapeutics TTM cash flow from financing activities is currently $34.49 million, with the most recent change of -$1.81 million (-4.99%) on 30 September 2024. Over the past year, it has increased by +$32.79 million (+1930.98%). CARA TTM CFF is now -75.90% below its all-time high of $143.12 million, reached on 30 September 2019.CARA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -162.2% | +1931.0% |
| 3 y3 years | -2.5% | -304.7% | -13.3% |
| 5 y5 years | -65.6% | -100.5% | -75.9% |
CARA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.1% | >+9999.0% | -101.5% | at low | -26.0% | >+9999.0% |
| 5 y | 5 years | -73.3% | >+9999.0% | -100.5% | at low | -75.9% | >+9999.0% |
| alltime | all time | -73.3% | >+9999.0% | -100.5% | at low | -75.9% | >+9999.0% |
Cara Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$694.00 K(+13.8%) | $34.49 M(-5.0%) |
| June 2024 | - | -$610.00 K(-10.9%) | $36.30 M(-1.7%) |
| Mar 2024 | - | -$685.00 K(-101.9%) | $36.91 M(-3.3%) |
| Dec 2023 | $38.15 M(>+9900.0%) | $36.48 M(+3168.4%) | $38.15 M(+2146.8%) |
| Sept 2023 | - | $1.12 M(>+9900.0%) | $1.70 M(+147.5%) |
| June 2023 | - | $0.00(-100.0%) | $686.00 K(-21.0%) |
| Mar 2023 | - | $560.00 K(+2445.5%) | $868.00 K(+179.1%) |
| Dec 2022 | $311.00 K(-99.3%) | $22.00 K(-78.8%) | $311.00 K(-99.3%) |
| Sept 2022 | - | $104.00 K(-42.9%) | $45.58 M(-0.5%) |
| June 2022 | - | $182.00 K(+5966.7%) | $45.81 M(-0.2%) |
| Mar 2022 | - | $3000.00(-100.0%) | $45.92 M(-1.5%) |
| Dec 2021 | $46.61 M(+19.1%) | $45.29 M(>+9900.0%) | $46.61 M(+17.1%) |
| Sept 2021 | - | $339.00 K(+15.7%) | $39.79 M(-0.1%) |
| June 2021 | - | $293.00 K(-57.4%) | $39.84 M(+0.2%) |
| Mar 2021 | - | $688.00 K(-98.2%) | $39.75 M(+1.6%) |
| Dec 2020 | $39.14 M(-72.6%) | $38.47 M(+9639.0%) | $39.14 M(+5499.4%) |
| Sept 2020 | - | $395.00 K(+96.5%) | $699.00 K(-99.5%) |
| June 2020 | - | $201.00 K(+168.0%) | $138.67 M(-2.6%) |
| Mar 2020 | - | $75.00 K(+167.9%) | $142.44 M(-0.1%) |
| Dec 2019 | $142.60 M(+28.7%) | $28.00 K(-100.0%) | $142.60 M(-0.4%) |
| Sept 2019 | - | $138.37 M(+3381.8%) | $143.12 M(+45.0%) |
| June 2019 | - | $3.97 M(+1598.3%) | $98.72 M(-10.9%) |
| Mar 2019 | - | $234.00 K(-57.0%) | $110.78 M(-0.0%) |
| Dec 2018 | $110.81 M | $544.00 K(-99.4%) | $110.81 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $93.97 M(+485.8%) | $110.45 M(+563.9%) |
| June 2018 | - | $16.04 M(+5999.2%) | $16.64 M(-81.1%) |
| Mar 2018 | - | $263.00 K(+43.7%) | $88.04 M(+0.1%) |
| Dec 2017 | $87.92 M(>+9900.0%) | $183.00 K(+21.2%) | $87.92 M(+0.1%) |
| Sept 2017 | - | $151.00 K(-99.8%) | $87.82 M(+0.2%) |
| June 2017 | - | $87.44 M(>+9900.0%) | $87.67 M(>+9900.0%) |
| Mar 2017 | - | $149.00 K(+79.5%) | $232.00 K(+88.6%) |
| Dec 2016 | $123.00 K(-99.8%) | $83.00 K(>+9900.0%) | $123.00 K(-186.0%) |
| Sept 2016 | - | $0.00(0.0%) | -$143.00 K(-100.2%) |
| June 2016 | - | $0.00(-100.0%) | $75.60 M(-0.0%) |
| Mar 2016 | - | $40.00 K(-121.9%) | $75.63 M(+0.0%) |
| Dec 2015 | $75.59 M(+30.4%) | -$183.00 K(-100.2%) | $75.59 M(-0.4%) |
| Sept 2015 | - | $75.74 M(>+9900.0%) | $75.89 M(>+9900.0%) |
| June 2015 | - | $29.00 K(+383.3%) | $234.00 K(+4.5%) |
| Mar 2015 | - | $6000.00(-94.5%) | $224.00 K(-99.6%) |
| Dec 2014 | $57.99 M(+589.0%) | $109.00 K(+21.1%) | $57.99 M(+0.7%) |
| Sept 2014 | - | $90.00 K(+373.7%) | $57.57 M(+0.2%) |
| June 2014 | - | $19.00 K(-100.0%) | $57.48 M(-11.3%) |
| Mar 2014 | - | $57.77 M(<-9900.0%) | $64.80 M(+669.9%) |
| Dec 2013 | $8.42 M(+231.3%) | -$311.00 K(<-9900.0%) | $8.42 M(-3.6%) |
| Sept 2013 | - | $0.00(-100.0%) | $8.73 M(0.0%) |
| June 2013 | - | $7.33 M(+426.9%) | $8.73 M(+526.9%) |
| Mar 2013 | - | $1.39 M | $1.39 M |
| Dec 2012 | $2.54 M(-72.2%) | - | - |
| Dec 2011 | $9.14 M | - | - |
FAQ
- What is Cara Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Cara Therapeutics?
- What is Cara Therapeutics annual CFF year-on-year change?
- What is Cara Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cara Therapeutics?
- What is Cara Therapeutics quarterly CFF year-on-year change?
- What is Cara Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cara Therapeutics?
- What is Cara Therapeutics TTM CFF year-on-year change?
What is Cara Therapeutics annual cash flow from financing activities?
The current annual CFF of CARA is $38.15 M
What is the all time high annual CFF for Cara Therapeutics?
Cara Therapeutics all-time high annual cash flow from financing activities is $142.60 M
What is Cara Therapeutics annual CFF year-on-year change?
Over the past year, CARA annual cash flow from financing activities has changed by +$37.84 M (+12167.20%)
What is Cara Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CARA is -$694.00 K
What is the all time high quarterly CFF for Cara Therapeutics?
Cara Therapeutics all-time high quarterly cash flow from financing activities is $138.37 M
What is Cara Therapeutics quarterly CFF year-on-year change?
Over the past year, CARA quarterly cash flow from financing activities has changed by -$1.81 M (-162.19%)
What is Cara Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CARA is $34.49 M
What is the all time high TTM CFF for Cara Therapeutics?
Cara Therapeutics all-time high TTM cash flow from financing activities is $143.12 M
What is Cara Therapeutics TTM CFF year-on-year change?
Over the past year, CARA TTM cash flow from financing activities has changed by +$32.79 M (+1930.98%)